Squarepoint Ops LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1,845,364
+344.3%
114,264
+1041.7%
0.00%
+300.0%
Q2 2023$415,332
-92.7%
10,008
-89.4%
0.00%
-95.7%
Q1 2023$5,696,220
+269.6%
94,716
+366.9%
0.02%
+187.5%
Q3 2022$1,541,000
+153.5%
20,286
+176.2%
0.01%
+166.7%
Q1 2022$608,000
-79.7%
7,344
-81.6%
0.00%
-62.5%
Q4 2021$2,997,000
-80.6%
39,922
-70.0%
0.01%
-81.8%
Q3 2021$15,482,000
-4.2%
133,266
+82.9%
0.04%
-27.9%
Q2 2021$16,159,000
+198.6%
72,846
+77.9%
0.06%
+90.6%
Q1 2021$5,412,000
+31.4%
40,947
+72.0%
0.03%
+3.2%
Q4 2020$4,120,000
+243.6%
23,811
+121.0%
0.03%
+93.8%
Q3 2020$1,199,000
-89.1%
10,774
-94.2%
0.02%
-91.0%
Q2 2020$11,030,000
+1670.5%
185,995
+1909.2%
0.18%
+1012.5%
Q1 2020$623,000
-77.6%
9,257
-71.9%
0.02%
-5.9%
Q4 2019$2,780,000
+251.0%
32,995
+211.4%
0.02%
+142.9%
Q3 2019$792,000
-79.3%
10,596
-82.5%
0.01%
-81.1%
Q2 2019$3,832,000
+112.4%
60,600
+61.8%
0.04%
+94.7%
Q1 2019$1,804,000
+85.4%
37,450
+28.9%
0.02%
+72.7%
Q4 2018$973,000
-37.7%
29,054
-2.5%
0.01%
-42.1%
Q3 2018$1,561,000
+79.6%
29,799
+7.3%
0.02%
+58.3%
Q2 2018$869,000
-14.0%
27,773
-40.1%
0.01%
-25.0%
Q1 2018$1,010,000
+213.7%
46,348
+190.9%
0.02%
+166.7%
Q4 2017$322,00015,9310.01%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders